| 11 |
A TLR4-dependent fibroblast-monocyte axis in tumor-draining lymph nodes contributes to metastasis in triple-negative breast cancer |
Department of Microbiology and Immunology |
2025 |
| 12 |
Advancing green and white assessment: DFT-assisted spectrofluorimetry for accurate favipiravir quantification in human plasma |
Department of Pharmaceutical Analytical Chemistry |
2025 |
| 13 |
AMPK Activation Downregulates TXNIP, Rab5, and Rab7 Within Minutes, Thereby Inhibiting the Endocytosis-Mediated Entry of Human Pathogenic Viruses |
Department of Microbiology and Immunology |
2025 |
| 14 |
Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article |
Department of Medicinal Chemistry |
2025 |
| 15 |
Antiparasitic efficacy of geraniol from Apiaceae family in scabies treatment |
Department of Pharmacognosy |
2025 |
| 16 |
Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent Advances |
Department of Medicinal Chemistry |
2025 |
| 17 |
Cobalt-induced oxidative stress and defense responses of Adhatoda vasica proliferated shoots |
Department of Pharmacognosy |
2025 |
| 18 |
Crystal structure and quantum chemical calculations of 2-(2'-oxospiro[1,3-dioxolane-2,3'-indol]-1'(2'H)-yl)acetohydrazide |
Department of Medicinal Chemistry |
2025 |
| 19 |
Design and synthesis of 5-substituted-2-Iminothiazolidin-4-one Derivatives as quorum sensing inhibitors against Pseudomonas aeruginosa virulence factors: An integrated study of molecular docking, dynamics, and biological assays |
Department of Medicinal Chemistry |
2025 |
| 20 |
Design, synthesis, and antiproliferative activity of new 5-ethylsulfonylindazole- 3-carbohydrazides as dual EGFR/VEGFR-2 kinases inhibitors |
Department of Pharmaceutical Organic Chemistry |
2025 |